Τίτλος – Title
|
Μελέτη της Σχέσης μεταξύ των Επιπέδων Θυρεοειδικής Ορμόνης στο Αίμα και Δεικτών Καρδιακής Λειτουργικότητας σε Ασθενείς με Χρόνια Καρδιακή Ανεπάρκεια και σε Επίμυες με Έμφραγμα του Μυοκαρδίου – |
|
Συγγραφέας – Author
|
Νικόλαος Τσιναράκης1, Νικόλαος Δρακούλης1, Ελευθερία Λειβα-δάρου1, Ιορδάνης Μουρούζης2, Κωνσταντίνος Πάντος2 1Τμήμα Φαρμακευτικής, Πανεπιστήμιο Αθηνών, Πανεπιστημιούπολη, Αθήνα, Ελλάς και 2Τομέας Φαρμακολογίας, Πανεπιστήμιο Αθηνών, Μικράς Ασίας 75, 11527 Γουδί, Αθήνα, Ελλάς Nikolaos Tsinarakis1, Nikolaos Drakoulis1, Eleftheria Leivadarou1, Iordanis Mourouzis2, Constantinos Pantos2 1Faculty of Pharmacy, Panepistimiopolis, Athens, and 2Laboratory of Pharmacology, Medical School, M Asias 75, 11527, National & Kapodistrian University, Athens, Hellas |
|
Παραπομπή – Citation
|
Τσιναράκης,Ν., Δρακούλης,Ν., Λειβαδάρου,Ε., Μουρούζης,Ι., Πάντος,Κ. : Μελέτη της Σχέσης μεταξύ των Επιπέδων Θυρεοειδικής Ορμόνης στο Αίμα και Δεικτών Καρδιακής Λειτουργικότητας σε Ασθενείς με Χρόνια Καρδιακή Ανεπάρκεια και σε Επίμυες με Έμφραγμα του Μυοκαρδίου, Επιθεώρηση Κλιν. Φαρμακολ. Φαρμακοκινητ. 27: 106-109 (2009)
–
|
|
Ημερομηνία Δημοσιευσης – Publication Date
|
8 Μαρτίου 2009 – 2009-03-08
|
|
Γλώσσα Πλήρους Κειμένου –
Full Text Language |
Ελληνικά – Greek |
|
Παραγγελία – Αγορά –
Order – Buy |
Ηλεκτρονική Μορφή: pdf (15 €) –
Digital Type: pdf (15 €) pharmakonpress[at]pharmakonpress[.]gr |
|
Λέξεις κλειδιά – Keywords
|
–
Thyroid hormone, thyroid nuclear receptors, heart failure, cardiac remodeling, low Τ3 syndrome, echocardiography hyperechography, ejection fraction
|
|
Λοιποί Όροι – Other Terms
|
Στατιστική Μελέτη Statistical Study |
|
Περίληψη – Summary
|
– During development of heart failure, extensive remodeling of the myocardium occurs, accompanied by alterations in the expression of functional and structural myocardial proteins in the direction of the fetal phenotype. It can be hypothesized that these changes are due to changes in the thyroid hormone system, since cardiovascular system appears to be targeted by thyroid hormones through thyroid nuclear receptors that regulate the expression of myocardial proteins. The present work studies the relation between thyroid hormone blood levels in patients with heart failure and the function of the myocardium based on echocardiographical indexes. Additionally, an experimental model of heart failure in rats was used to test the hypothesis that the thyroid hormone administration in heart failure patients may assist them therapeutically, inducing cardiac remodeling. In the clinical study, 45 patients were included. Myocardial performance was assessed by echocardiography and total T3, T4 and TSH were measured in serum. Total T3 was strongly correlated with EF% (r=0.51, p=0.00037). A weaker but significant correlation was also found between T3 and LA (r=-0.35, p=0.028). In experimental study 27 male rats were included. Myocardial performance was assessed echocardiographicaly and ex vivo. Total T3, T4 were measured in serum and electrophoresis, after proper manipulations, of a small piece of left ventricular tissue from each sample was made to evaluate MHCα and MHCβ levels. Left ventricular internal diameters, LVIDs, of the AMI-THYR group were found to be significantly smaller than those of the AMI group. A significant augmentation of the left ventricular ejection fraction, LVEF%, of the AMI-THYR group relative to the AMI group was also observed (p<0.05). The systolic velocity of the posterior wall, SVPW, was found to be increased in the AMI-THYR group compaired to the two other groups (p<0.05). In the 13th week an important reduction in heart function was noticed as far as the AMI group was concerned. In contrast, normal contractility indexes were noted in the AMI-THYR group (p<0.05). Finally, thyroid hormone administration was found to alter the expression myosin isoforms. Τhere was a statistically significant increase in the MHCα isoform versus the MHCβ isoform (p<0.05). |
|
Αναφορές – References
|
1. Klein I., Ojamaa K.: Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344: 501-509 (2001)
2. Pantos C., Malliopoulou V., Varonos D.D., Cokkinos D.V.: Thyroid hormone and phenotypes of cardioprotection. Bas. Res. Cardiol. 99: 101-120 (2004) 3. Ascheim D.D., Hryniewicz K.: Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. Thyroid 12: 511-515 (2002) 4. Manowitz N., Mayor G., Klepper M., DeGroot L.: Subclinical Hypothyroidism and Euthyroid Sick Syndrome in Patients with Moderate-to-Severe Congestive Heart Failure. Am. J. Ther. 3: 797-801 (1996) 5. Pingitore A., Landi P., Taddei M,C,, Ripoli A,, L’Abbate A,, Iervasi G.: Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am. J. Med. 118: 132-136 (2005) 6. Kinugawa K, Yonekura K, Ribeiro RC, Eto Y, Aoyagi T, Baxter JD, Camacho SA, Bristow MR, Long CS, Simpson PC. Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy. Circulation Res. 89: 591-598 (2001) 7. Pantos C., Mourouzis I., Saranteas T., Paizis I., Xinaris C., Malliopoulou V., Cokkinos D.V. : Thyroid hormone receptors α1 and β1 are downregulated in the post-infarcted rat heart: consequences on the response to ischaemia-reperfusion. Bas. Res. Cardiol. 100: 422-432 (2005) 8. Pantos C., Mourouzis I., Xinaris C., Kokkinos A.D., Markakis K., Dimopoulos A., Panagiotou M., Saranteas T., Kostopanagiotou G., Cokkinos D.V.: Time-dependent changes in the expression of thyroid hormone receptor alpha 1 in the myocardium after acute myocardial infarction: possible implications in cardiac remodelling. Eur. J. Endocrinol. 156: 415-424 (2007) 9. D’Amati G., di Gioia C.R., Mentuccia D., Pistilli D., Proietti-Pannunzi L., Miraldi F., Gallo P., Celi F.S.: Increased expression of thyroid hormone receptor isoforms in end-stage human congestive heart failure. J. Clin. Endocrinol. Metab. 86: 2080-2084 (2001) |
Online ISSN 1011-6575
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση-Οδηγίες προς τους Συγγραφείς
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition-Instrunctions to Authors
Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition
Συντακτικη Επιτροπή-Editorial Board
ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ – ANNUAL SUBSCRIPTION
|
||
Γλώσσα Πλήρους Κειμένου –
Full Text Language |
Ελληνικά – Greek
|
|
Παραγγελία – Αγορά –
Order – Buy |
pharmakonpress[at]pharmakonpress[.]gr
|
|
pharmakonpress[at]pharmakonpress[.]gr
|